Sukumar Nagendran

Sukumar Nagendran is an accomplished senior medical executive currently serving as President of Taysha Gene Therapy and contributing as a board member for several organizations including Solid Biosciences and Medocity, Inc. With extensive experience in gene therapy and medical affairs, Sukumar has held prominent roles such as President and Chief Medical Officer at Jaguar Gene Therapy and has led medical operations at various major pharmaceutical companies. They received their MD from Rutgers Robert Wood Johnson Medical School and completed their residency in Internal Medicine at the Mayo Clinic. Over the years, Sukumar has played a significant role in advancing medical strategies across multiple therapeutic areas.